The OPT-SMC project comes to a successful end

As we mark World Malaria Day, we celebrate the achievements of the OPT-SMC (Optimizing Seasonal Malaria Chemoprevention) project, which is now concluding after five years of impactful implementation. The project leaves behind many success stories to celebrate and lessons learnt for future projects.

Despite efforts to reduce the burden of malaria, nearly 600 000 people died of malaria in 2023 and one in every five of those deaths were in children under five. Therefore, it is essential that countries continue to optimize life-saving malaria prevention interventions such as Seasonal Malaria Chemoprevention (SMC).

The project was developed to strengthen the capacity of national malaria programmes in conducting implementation research to tailor SMC to the local context, ultimately improving its delivery and impact. With funding from the European and Developing Countries Clinical Trials Partnership (EDCTP), grants and technical assistance was provided to support 13 countries across West Africa and Central Africa – namely  Benin, Burkina Faso, Cameroon, Chad, The Gambia, Ghana, Guinea, Guinea-Bissau, Mali, Mauritania, Niger, Nigeria, Senegal and Togo - to enable the implementation of projects and facilitate in sharing of information and expertise.

In partnership with the University of Thiès in Senegal, the Special Programme for Research and Training in Tropical disease (TDR), Medicines for Malaria Venture (MMV), and the London School of Hygiene and Tropical Medicine (LSHTM), these countries conducted implementation research focused on: understanding community perceptions of SMC; improving the coverage and quality of SMC delivery; identifying the facilitators and barriers to SMC uptake ans strengthening monitoring and evaluation systems. The project also helped the National Malaria Programmes (NMPs) to effectively target high-risk populations and create a platform of knowledge and experience sharing for countries involved.

Beyond the results gathered from the projects themselves, NMPs representatives testified that the OPT-SMC project has helped them improve upon their research, monitoring capabilities. The project has also helped them gather better evidence on the burden of malaria among young children which will be useful for outreach to potential donors in the future. As a byproduct of the project, some countries were also able to develop a database for capturing research evidence. They were also very pleased that they could learn from other implementing countries and apply their lessons learnt.

Findings from the project have been disseminated at key international conferences, including the American Society of Tropical Medicine and Hygiene (ASTMH), 8th Multilateral Initiative on Malaria (MIM) Society Conference and the EDCTP Forum.

The strong network and momentum created by the OPT-SMC project will serve as a solid foundation for the next chapter: the OPT-MVAC project which aims to optimize the delivery and uptake of malaria vaccines in countries with areas of highly seasonal transmission in West and Central Africa.

As we look ahead, the lessons of OPT-SMC remind us that impactful change happens when countries lead, collaborate, and innovate together in the fight against malaria.